CRDF — Cardiff Oncology Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates CRDF Bearish with a Setup Score of 50, net conviction 36, actionability 70. How the Setup Score works →

Total Setup Score50
Directional BiasBearish
Net Conviction36
Actionability70 (in range)

Key signals behind this score

About Cardiff Oncology Inc

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$1.33
Market Cap$90.2M
Float66.7M
Shares Outstanding68.4M
Price/Sales (TTM)171.90
vs. Analyst Target+292.1% to analyst PT
Operating Margin (TTM)-31341.46%
Revenue (TTM)$525,000
Dividend RateNone
Analyst Target Price$5.21 (7 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $366,000 -$19.3M $366,000 -$18.8M
2021 $359,000 -$28.3M $359,000 -$27.8M
2022 $386,000 -$38.7M $386,000 -$38.5M
2023 $488,000 -$41.4M $488,000 -$41.0M
2024 $683,000 -$45.4M $683,000 -$45.0M
2025 $593,000 -$45.9M $593,000 -$44.9M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $121,000 -$13.9M
Sep 2025 $120,000 -$11.3M
Dec 2025 $243,000 -$7.2M
Mar 2026 $41,000 -$12.3M

Ownership & Float

Insider Ownership5.9%
Institutional Ownership32.8%
Short Float24.2%
% of All Funds Holding1.27%
Number of Funds Holding104

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.51Near-term / short-term trend
Weekly40-Week SMA$1.96Medium-term trend
Weekly80-Week SMA$2.60Cyclical trend (business cycle)
Weekly200-Week SMA$2.34Secular trend (multi-year)
Monthly10-Month SMA$1.90Near-term monthly trend
Monthly20-Month SMA$2.53Medium-term monthly trend
Monthly40-Month SMA$2.39Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$1.70 resistance 1.79x 0 months ago
$2.80 resistance 1.31x 5 months ago
$3.10 resistance 1.86x 11 months ago
$4.30 resistance 1.01x 15 months ago

Historical Earnings Reactions (56 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -1.00% -0.51% 39.29% 12.99% -20.00%
1 Day 0.24% -0.47% 44.64% 64.41% -25.71%
1 Week 3.04% -0.75% 42.86% 133.90% -36.92%
2 Weeks 5.09% -1.96% 42.86% 184.18% -40.10%
1 Month 5.34% -4.11% 40.00% 201.13% -74.40%

Next earnings: August 4, 2026 (24 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-4.1%36.4%22
Feb1.3%50.0%22
Mar2.4%31.8%22
Apr-3.3%36.4%22
May-1.3%36.4%22
Jun2.7%31.8%22
Jul7.6%33.3%21
Aug7.1%59.1%22
Sep-0.2%27.3%22
Oct-1.2%40.9%22
Nov4.5%40.9%22
Dec1.3%40.9%22

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.10% 33.6% 1034
Tuesday -0.09% 31.8% 1133
Wednesday 0.08% 34.8% 1134
Thursday 0.27% 34.5% 1112
Friday 0.26% 34.8% 1106

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 32.8%

Insider Transactions — Smart Summary

Total insider ownership: 5.9%

12-Month Insider Activity Summary

Total Filings3
Net Value+$29,890.63
Net Shares Change344,703
% of Float0.5%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
PACE GARY W +$747,100 2 3 buy
Mohindru Mani Chief Executive Officer +$29,890.63 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-06-22 Mohindru Mani Chief Executive Officer +$29,890.63 Transaction at $1.21, now +9.9%
2026-06-22 PACE GARY W +$36,600 Transaction at $1.22, now +9.0%
2025-07-31 PACE GARY W +$710,500 Transaction at $2.45, now -45.7%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Cardiff Oncology Inc (CRDF) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CRDF on Trend Edge →